ClinicalTrials.gov record
Completed Phase 3 Interventional

Efficacy of Riluzole in Surgical Treatment for Cervical Spondylotic Myelopathy (CSM-Protect)

ClinicalTrials.gov ID: NCT01257828

Public ClinicalTrials.gov record NCT01257828. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 8:10 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy of Riluzole in Patients With Cervical Spondylotic Myelopathy Undergoing Surgical Treatment. A Randomized, Double-Blind, Placebo-controlled Multi-Center Study

Study identification

NCT ID
NCT01257828
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AOSpine North America Research Network
Network
Enrollment
270 participants

Conditions and interventions

Interventions

  • Placebo medication Drug
  • riluzole Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 29, 2012
Primary completion
Dec 14, 2017
Completion
May 31, 2018
Last update posted
Nov 1, 2018

2012 – 2018

United States locations

U.S. sites
15
U.S. states
13
U.S. cities
14
Facility City State ZIP Site status
Barrow Neurological Institute Phoenix Arizona 85013
UC Davis Spine Center Sacramento California 95816
University of California - San Francisco San Francisco California 94143
Emory University School of Medicine Atlanta Georgia 30329
Rush University Medical Center Chicago Illinois 60612
Kansas University Medical Center Kansas City Kansas 66160
Louisiana State University Baton Rouge Louisiana 70803
Mayo Clinic Rochester Minnesota 55905
Washington University Orthopaedics St Louis Missouri 63110
The Ohio State University Columbus Ohio 43210
Rothman Institute Orthopaedics Philadelphia Pennsylvania 19107
Thomas Jefferson University Philadelphia Pennsylvania 19107
University of Utah Salt Lake City Utah 84108
University of Virginia Charlottesville Virginia 22908
Harborview Medical Center Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01257828, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 1, 2018 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01257828 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →